Systematic Financial Management LP bought a new stake in shares of Healthpeak Properties, Inc. (NYSE:DOC - Free Report) in the 3rd quarter, according to its most recent filing with the SEC. The institutional investor bought 1,420,387 shares of the real estate investment trust's stock, valued at approximately $32,484,000. Systematic Financial Management LP owned about 0.20% of Healthpeak Properties at the end of the most recent reporting period.
Several other hedge funds have also made changes to their positions in the stock. Charles Schwab Investment Management Inc. acquired a new stake in shares of Healthpeak Properties in the 3rd quarter valued at $230,988,000. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC bought a new position in shares of Healthpeak Properties in the 3rd quarter valued at about $175,697,000. Sumitomo Mitsui Trust Group Inc. acquired a new position in shares of Healthpeak Properties in the 3rd quarter valued at $102,615,000. Heitman Real Estate Securities LLC bought a new stake in shares of Healthpeak Properties in the 3rd quarter valued at about $69,118,000. Finally, FMR LLC acquired a new stake in shares of Healthpeak Properties in the 3rd quarter valued at approximately $67,058,000. Institutional investors own 93.57% of the company's stock.
Healthpeak Properties Price Performance
NYSE DOC traded up $0.23 during trading on Thursday, hitting $21.53. 2,113,448 shares of the company's stock were exchanged, compared to its average volume of 5,672,158. The stock's 50 day moving average price is $22.11 and its two-hundred day moving average price is $21.27. The company has a market cap of $15.06 billion, a PE ratio of 45.32, a P/E/G ratio of 2.39 and a beta of 1.13. Healthpeak Properties, Inc. has a fifty-two week low of $16.01 and a fifty-two week high of $23.26. The company has a current ratio of 1.31, a quick ratio of 1.31 and a debt-to-equity ratio of 0.93.
Healthpeak Properties (NYSE:DOC - Get Free Report) last announced its quarterly earnings results on Thursday, October 24th. The real estate investment trust reported $0.12 EPS for the quarter, missing analysts' consensus estimates of $0.44 by ($0.32). Healthpeak Properties had a net margin of 12.10% and a return on equity of 3.53%. The firm had revenue of $700.40 million during the quarter, compared to the consensus estimate of $682.51 million. During the same quarter in the previous year, the company posted $0.45 earnings per share. The firm's revenue was up 25.9% on a year-over-year basis. Research analysts expect that Healthpeak Properties, Inc. will post 1.8 EPS for the current year.
Healthpeak Properties Announces Dividend
The firm also recently disclosed a quarterly dividend, which was paid on Friday, November 15th. Investors of record on Monday, November 4th were issued a $0.30 dividend. The ex-dividend date was Monday, November 4th. This represents a $1.20 dividend on an annualized basis and a yield of 5.57%. Healthpeak Properties's dividend payout ratio (DPR) is presently 255.32%.
Wall Street Analyst Weigh In
Several analysts recently commented on DOC shares. Robert W. Baird raised their price objective on Healthpeak Properties from $24.00 to $25.00 and gave the stock an "outperform" rating in a research note on Wednesday, October 30th. Citigroup increased their target price on Healthpeak Properties from $20.00 to $22.00 and gave the stock a "neutral" rating in a research note on Thursday, August 22nd. Royal Bank of Canada raised their target price on shares of Healthpeak Properties from $25.00 to $26.00 and gave the company an "outperform" rating in a research report on Monday, November 4th. Mizuho reduced their price objective on shares of Healthpeak Properties from $25.00 to $24.00 and set an "outperform" rating for the company in a research note on Thursday. Finally, Evercore ISI upped their target price on Healthpeak Properties from $25.00 to $26.00 and gave the stock an "outperform" rating in a report on Monday, September 16th. One research analyst has rated the stock with a sell rating, five have issued a hold rating, ten have issued a buy rating and one has issued a strong buy rating to the company's stock. According to MarketBeat, the stock presently has a consensus rating of "Moderate Buy" and a consensus target price of $23.00.
Get Our Latest Stock Report on Healthpeak Properties
Healthpeak Properties Company Profile
(
Free Report)
Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.
Read More
Before you consider Healthpeak Properties, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Healthpeak Properties wasn't on the list.
While Healthpeak Properties currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Options trading isn’t just for the Wall Street elite; it’s an accessible strategy for anyone armed with the proper knowledge. Think of options as a strategic toolkit, with each tool designed for a specific financial task. Keep reading to learn how options trading can help you use the market’s volatility to your advantage.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.